We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Addiction
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Most people treated for heroin addiction are prescribed methadone which enables them to stop heroin use safely avoiding
withdrawal. People starting methadone take a daily dose under a pharmacist’s supervision. Supervision prevents overdose. If a patient
misses their daily methadone they will experience opiate withdrawal and cravings which make them more likely to use heroin. If they miss
methadone for three days, people lose their tolerance to the drug and risk overdose. Unfortunately many patients do miss their doses. Research shows that small financial incentives can improve medication adherence. We have developed the technology to deliver such incentives using mobile phones but need to test the feasibility of this approach before conducting a full trial. The research aims to assess the feasibility of a trial to test whether attendance with supervised methadone consumption in pharmacies can be improved by using incentives delivered by mobile phone.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31909291/ protocol (added 26/10/2020)2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33407950/ results (added 08/01/2021)
You can take part if:
You may not be able to take part if:
1. Cannot read English AND would require the service of an interpreter to understand a brief oral description of the study2. Already entered the trial.3. Previously attended the service (drug clinic) and were discharged within the last three weeks
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Nicola
Metrebian
02078480359
nicola.metrebian@kcl.ac.uk
The study is sponsored by Kings College London & South London & Maudsley NHS Foundation Trust and funded by National Institute for Health Research.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 39867
You can print or share the study information with your GP/healthcare provider or contact the research team directly.